Menu
GWAS Study

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.

Taira M, Imamura M, Takahashi A et al.

30566433 PubMed ID
GWAS Study Type
13035 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TM
Taira M
IM
Imamura M
TA
Takahashi A
KY
Kamatani Y
YT
Yamauchi T
AS
Araki SI
TN
Tanaka N
VZ
van Zuydam NR
AE
Ahlqvist E
TM
Toyoda M
UT
Umezono T
KK
Kawai K
IM
Imanishi M
WH
Watada H
SD
Suzuki D
MH
Maegawa H
BT
Babazono T
KK
Kaku K
KR
Kawamori R
GL
Groop LC
MM
McCarthy MI
KT
Kadowaki T
MS
Maeda S
Chapter II

Abstract

Summary of the research findings

To explore novel genetic loci for diabetic nephropathy, we performed genome-wide association studies (GWAS) for diabetic nephropathy in Japanese patients with type 2 diabetes. We analyzed the association of 5,768,242 single nucleotide polymorphisms (SNPs) in Japanese patients with type 2 diabetes, 2,380 nephropathy cases and 5,234 controls. We further performed GWAS for diabetic nephropathy using independent Japanese patients with type 2 diabetes, 429 cases and 358 controls and the results of these two GWAS were combined with an inverse variance meta-analysis (stage-1), followed by a de novo genotyping for the candidate SNP loci (p < 1.0 × 10(-4)) in an independent case-control study (Stage-2; 1,213 cases and 1,298 controls). After integrating stage-1 and stage-2 data, we identified one SNP locus, significantly associated with diabetic nephropathy; rs56094641 in FTO, P = 7.74 × 10(-10). We further examined the association of rs56094641 with diabetic nephropathy in independent Japanese patients with type 2 diabetes (902 cases and 1,221 controls), and found that the association of this locus with diabetic nephropathy remained significant after integrating all association data (P = 7.62 × 10(-10)). We have identified FTO locus as a novel locus for conferring susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.

2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

13035
Total Participants
GWAS
Study Type
Yes
Replicated
2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls
Replication Participants
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.